Thomas Struengmann & family: Thomas Struengmann & family Net Worth, Biography, Age, Spouse, Children & More

About Thomas Struengmann & family

Thomas Strüngmann, born in 1950, and his brother Andreas, established themselves as pharmaceutical magnates by co-founding generic drug maker Hexal AG in 1986, and then selling it for a massive $6.7 billion in 2005. Their current investment prominence stems from owning roughly 50% of BioNTech SE—the German biotech innovator allied with Pfizer in crafting the COVID-19 vaccine—where they earned $8 billion. They manage their extensive healthcare fortune, including stakes in 4SC and Immatics, from their family office, Athos Service.

Born

February 16, 1950

Age

76 years

Source Of Wealth

Pharmaceuticals

Industries

Healthcare

Citizenship

Germany

Residence

Tegernsee

Education

Master of Business Administration, University of Augsburg; Master of Business Administration, University of Augsburg

Thomas Strüngmann was born in 1950. Information about his early years and childhood is not publicly available.

Thomas Struengmann & family: Family

Thomas Strüngmann is the son of pharmacists Gustav and Maria Strüngmann. He has a brother named Andreas Strüngmann, who is also a successful businessman and co-founder of Hexal AG.

Thomas Struengmann & family: Career Highlights

Thomas Strüngmann co-founded Hexal AG, a generic drug maker, in 1986. He served as the company's CEO until 2005 when he sold it for $6.7 billion. Strüngmann also earned $8 billion on his stake in BioNTech SE, the German company developing the Pfizer–BioNTech COVID-19 vaccine.

Thomas Struengmann & family: Companies

Thomas Strüngmann currently owns approximately 50% of BioNTech SE. He also has significant ownership in 4SC and Immatics.

Thomas Struengmann & family: Major Achievements

Thomas Strüngmann is best known for co-founding Hexal AG and for his significant ownership in BioNTech SE. He is currently the largest health-care earned fortune with his brother Andreas.

Thomas Struengmann & family: Awards & Achievements

Thomas Strüngmann has not received any notable awards or achievements.

Thomas Struengmann & family: Personal Life & Legacy

Thomas Strüngmann is married and has two children. He is a private person and does not share much information about his personal life. However, he is known for his philanthropy and has donated millions of dollars to various charities.

Thomas Struengmann & family: Trivia

Thomas Strüngmann operates out of a family office, Athos Service.

Wealth History

Timeline

1950

Thomas Strüngmann was born.

1986

Thomas Strüngmann co-founded Hexal AG, a generic drug maker.

2005

Thomas Strüngmann sold Hexal for $6.7 billion.

2020

Thomas Strüngmann earned $8 billion on their stake in BioNTech SE, the German company developing the Pfizer–BioNTech COVID-19 vaccine.

Present

Thomas Strüngmann owns approximately 50% of BioNTech SE.

Present

Thomas Strüngmann has significant ownership in 4SC and Immatics.

Present

Thomas Strüngmann currently has the largest health-care earned fortune with his brother Andreas.

Present

Thomas Strüngmann operates out of a family office, Athos Service.

Thomas Struengmann & family : FAQs

What is Thomas Struengmann's current net worth?

Thomas Struengmann's current net worth is $11.00 billion.

What is Thomas Struengmann's current global rank among billionaires?

Thomas Struengmann holds the 281st position globally among billionaires.

What is Thomas Struengmann's current ranking within the Germany?

Thomas Struengmann holds the 15th position in Germany.

What was the change in Thomas Struengmann's net worth compared to the previous year?

Thomas Struengmann's net worth increased by 340.69 million dollars compared to the previous year 2025, when his net worth was 10.66 billion dollars.

What are Thomas Struengmann's main sources of wealth?

Thomas Struengmann's main source of income comes from Pharmaceuticals.

In which industry does Thomas Struengmann primarily operate?

Thomas Struengmann is primarily involved in the Healthcare industry.

What is Thomas Struengmann educational background?

Thomas Struengmann holds a Master of Business Administration from the University of Augsburg and a Master of Business Administration from the University of Augsburg.

How old is Thomas Struengmann?

Thomas Struengmann is 76 years old.

How many children does Thomas Struengmann have?

Thomas Struengmann has 4 children.

Who is Thomas Strüngmann and when was he born?

Thomas Strüngmann is a noted entrepreneur and the co-founder of Hexal AG, a generic drug maker. He was born in the year 1950.

What is Hexal AG and who founded it?

Hexal AG is a company that produces generic drugs, and it was co-founded by Thomas Strüngmann and his brother in 1986.

How much did Thomas Strüngmann sell Hexal AG for and when?

Thomas Strüngmann sold Hexal AG for $6.7 billion in the year 2005.

What stake does Thomas Strüngmann have in BioNTech SE?

Thomas Strüngmann owns approximately 50% of BioNTech SE, the German biotechnology company involved in developing the Pfizer-BioNTech COVID-19 vaccine.

What other companies does Thomas Strüngmann have significant ownership in?

Besides BioNTech SE, Thomas Strüngmann has significant ownership in the biotechnology firms 4SC and Immatics.